Purple Biotech Ltd. Holds Shareholder Meeting
Ticker: PPBT · Form: 6-K · Filed: Dec 16, 2025 · CIK: 1614744
Sentiment: neutral
Topics: shareholder-meeting, corporate-governance, foreign-private-issuer
TL;DR
Purple Biotech held its shareholder meeting on Dec 15, 2025.
AI Summary
Purple Biotech Ltd. announced the results of its Extraordinary General Meeting of Shareholders held on December 15, 2025. The meeting took place at the Company's offices in Rehovot, Israel.
Why It Matters
Shareholder meetings are crucial for corporate governance, allowing investors to vote on important company matters and influence strategic decisions.
Risk Assessment
Risk Level: low — This filing is a routine report of a shareholder meeting and does not contain significant financial or operational news.
Key Players & Entities
- Purple Biotech Ltd. (company) — Registrant
- December 15, 2025 (date) — Date of Shareholder Meeting
- Rehovot, Israel (location) — Company's office location
FAQ
What type of report is this filing?
This filing is a Form 6-K, a Report of Foreign Private Issuer.
When was the Extraordinary General Meeting of Shareholders held?
The meeting was held on December 15, 2025.
Where did the shareholder meeting take place?
The meeting took place at the Company's offices in Rehovot, Israel.
What is the company's principal executive office address?
The address is 4 Oppenheimer Street, Science Park, Rehovot 7670104, Israel.
Has Purple Biotech Ltd. changed its name previously?
Yes, the company was formerly known as Kitov Pharma Ltd. (name change effective January 25, 2018) and Kitov Pharmaceuticals Holdings Ltd. (name change effective July 24, 2014).
Filing Stats: 598 words · 2 min read · ~2 pages · Grade level 20 · Accepted 2025-12-16 16:00:26
Filing Documents
- ea0269858-6k_purple.htm (6-K) — 13KB
- 0001213900-25-122236.txt ( ) — 14KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. December 16, 2025 PURPLE BIOTECH LTD. By: /s/ Gil Efron Gil Efron Chief Executive Officer 2